Rituximab Raises Remission Rate in GPA Vasculitis ...Middle East

Remission at 6 months was recorded in 73.1% of rituximab-treated patients and 40.1% of cyclophosphamide-treated patients in a multicenter target trial emulation. MDedge News

Read More Details
Finally We wish PressBee provided you with enough information of ( Rituximab Raises Remission Rate in GPA Vasculitis )

Also on site :

• Vacaville carjacking suspects arrested in Fairfield; suspect shot by police
• UK government suspends free trade talks with Israel over Gaza war
• Jeff Bezos spanks bikini-clad Lauren Sanchez as she sunbathes on their $500M superyacht